Similar articles for PMID: 29133496

Year	Number of Results
1807	1
1815	1
1902	1
1903	1
1906	1
1946	1
1947	1
1948	1
1949	1
1951	1
1953	1
1955	1
1956	3
1961	3
1962	2
1963	1
1967	1
1970	1
1973	1
1976	2
1981	1
1982	1
1986	1
1987	1
1988	1
1989	1
1994	1
1995	1
1996	1
1998	1
2000	3
2001	2
2002	2
2004	1
2005	2
2006	5
2007	2
2008	5
2009	8
2010	6
2011	10
2012	11
2013	6
2014	12
2015	15
2016	13
2017	13
2018	21
2019	9
2020	10
2021	8

1

Factors Influencing Allopurinol Initiation in Primary Care.

Clarson LE, Hider SL, Belcher J, Roddy E, Mallen CD. Clarson LE, et al. Ann Fam Med. 2017 Nov;15(6):557-560. doi: 10.1370/afm.2137. Ann Fam Med. 2017. PMID: 29133496 Free PMC article.

2

Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease.

Mitri G, Wittbrodt ET, Turpin RS, Tidwell BA, Schulman KL. Mitri G, et al. J Manag Care Spec Pharm. 2016 Apr;22(4):326-36. doi: 10.18553/jmcp.2016.22.4.326. J Manag Care Spec Pharm. 2016. PMID: 27023686

3

Adherence and persistence to urate-lowering therapies in the Irish setting.

McGowan B, Bennett K, Silke C, Whelan B. McGowan B, et al. Clin Rheumatol. 2016 Mar;35(3):715-21. doi: 10.1007/s10067-014-2823-8. Epub 2014 Nov 20. Clin Rheumatol. 2016. PMID: 25409858

4

An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.

Robinson PC, Taylor WJ, Dalbeth N. Robinson PC, et al. J Rheumatol. 2015 Sep;42(9):1702-7. doi: 10.3899/jrheum.150310. Epub 2015 Aug 1. J Rheumatol. 2015. PMID: 26233513 Free article.

5

Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.

Vargas-Santos AB, Peloquin CE, Zhang Y, Neogi T. Vargas-Santos AB, et al. JAMA Intern Med. 2018 Nov 1;178(11):1526-1533. doi: 10.1001/jamainternmed.2018.4463. JAMA Intern Med. 2018. PMID: 30304329 Free PMC article.

6

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.

Chohan S, Becker MA, MacDonald PA, Chefo S, Jackson RL. Chohan S, et al. Arthritis Care Res (Hoboken). 2012 Feb;64(2):256-61. doi: 10.1002/acr.20680. Arthritis Care Res (Hoboken). 2012. PMID: 22052584 Free article. Clinical Trial.

7

Does starting allopurinol prolong acute treated gout? A randomized clinical trial.

Hill EM, Sky K, Sit M, Collamer A, Higgs J. Hill EM, et al. J Clin Rheumatol. 2015 Apr;21(3):120-5. doi: 10.1097/RHU.0000000000000235. J Clin Rheumatol. 2015. PMID: 25807090 Clinical Trial.

8

Impact of allopurinol use on urate concentration and cardiovascular outcome.

Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM. Wei L, et al. Br J Clin Pharmacol. 2011 Apr;71(4):600-7. doi: 10.1111/j.1365-2125.2010.03887.x. Br J Clin Pharmacol. 2011. PMID: 21395653 Free PMC article.

9

Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.

Singh JA, Akhras KS, Shiozawa A. Singh JA, et al. Arthritis Res Ther. 2015 May 12;17(1):120. doi: 10.1186/s13075-015-0624-3. Arthritis Res Ther. 2015. PMID: 25963969 Free PMC article.

10

Allopurinol initiation and all-cause mortality in the general population.

Dubreuil M, Zhu Y, Zhang Y, Seeger JD, Lu N, Rho YH, Choi HK. Dubreuil M, et al. Ann Rheum Dis. 2015 Jul;74(7):1368-72. doi: 10.1136/annrheumdis-2014-205269. Epub 2014 Mar 24. Ann Rheum Dis. 2015. PMID: 24665118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed